Listar ImmunoConcEpT - UMR 5164 por autor "KAMINSKI, Hannah"
Mostrando ítems 1-6 de 6
-
The incidence of post-transplant malignancies in kidney transplant recipients treated with Rituximab
BACHELET, T.; VISENTIN, Jonathan; DAVIS, P. ...(Clinical Transplantation. vol. 35, n° 2, pp. e14171, 2021-02)Article de revue -
Unconventional T cells and kidney disease
KAMINSKI, Hannah; COUZI, Lionel; EBERL, M.(Nature Reviews Nephrology. vol. 17, n° 12, pp. 795-813, 2021-08-26)Article de revue -
Immunological exhaustion: How to make a disparate concept operational?
KAMINSKI, Hannah; LEMOINE, Mael; PRADEU, Thomas(PLoS Pathogens. vol. 17, n° 9, 2021-09-23)Article de revueLibre acceso -
Comparison of two strategies based on mammalian target of rapamycin inhibitors in secondary prevention of non-melanoma skin cancer after kidney transplantation, a pilot study
PRETERRE, J.; VISENTIN, Jonathan; SAINT CRICQ, M. ...(Clinical Transplantation. vol. 35, n° 3, 2021-03)Article de revue -
Characterization of a Unique γδ T-Cell Subset as a Specific Marker of Cytomegalovirus Infection Severity
KAMINSKI, Hannah; MENARD, C.; EL HAYANI, Bouchra ...(Journal of Infectious Diseases. vol. 223, n° 4, pp. 655-666, 2021-02)Article de revue -
Reply to Coussement et al
KAMINSKI, Hannah; BELLIERE, J.; COUZI, Lionel ...(Clinical Infectious Diseases. vol. 73, n° 4, pp. 753-754, 2021-08-15)Article de revue